Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Gross Profit (2023 - 2025)

Historic Gross Profit for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Q3 2025 value amounting to $43.3 million.

  • Phathom Pharmaceuticals' Gross Profit rose 20947.41% to $43.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.4 million, marking a year-over-year increase of 48520.39%. This contributed to the annual value of $47.3 million for FY2024, which is 908038.83% up from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Gross Profit of $43.3 million as of Q3 2025, which was up 20947.41% from $34.5 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Gross Profit registered a high of $43.3 million during Q3 2025, and its lowest value of $515000.0 during Q4 2023.
  • For the 3-year period, Phathom Pharmaceuticals' Gross Profit averaged around $18.8 million, with its median value being $19.4 million (2024).
  • As far as peak fluctuations go, Phathom Pharmaceuticals' Gross Profit surged by 491922.33% in 2024, and later soared by 20947.41% in 2025.
  • Phathom Pharmaceuticals' Gross Profit (Quarter) stood at $515000.0 in 2023, then surged by 4919.22% to $25.8 million in 2024, then skyrocketed by 67.57% to $43.3 million in 2025.
  • Its Gross Profit stands at $43.3 million for Q3 2025, versus $34.5 million for Q2 2025 and $24.8 million for Q1 2025.